These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7119510)

  • 1. The kidney is the main site of interferon degradation.
    Bino T; Madar Z; Gertler A; Rosenberg H
    J Interferon Res; 1982; 2(2):301-8. PubMed ID: 7119510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the kidney in catabolism of human leukocyte interferon.
    Bino T; Edery H; Gertler A; Rosenberg H
    J Gen Virol; 1982 Mar; 59(Pt 1):39-45. PubMed ID: 6175730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of [125I]-labeled human leukocyte-derived alpha interferon in the rat.
    Rosenberg H; Madar Z; Gertler A; Rubinstein M; Bino T
    J Interferon Res; 1985; 5(1):121-7. PubMed ID: 3989334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of serum albumin by rat liver and kidney lysosomes.
    Ohshita T; Hiroi Y
    J Nutr Sci Vitaminol (Tokyo); 1998 Oct; 44(5):641-53. PubMed ID: 9919484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of human fibroblast interferon in rats].
    Satoh Y; Kasama K; Usuki K; Naruse N; Ida N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):301-6. PubMed ID: 6696463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance and tissue distribution of recombinant human interleukin 1 beta in rats.
    Kudo S; Mizuno K; Hirai Y; Shimizu T
    Cancer Res; 1990 Sep; 50(18):5751-5. PubMed ID: 2393849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue locations for the turnover of radioactively labeled rat orosomucoid in vivo.
    Kuranda MJ; Aronson NN
    Arch Biochem Biophys; 1983 Jul; 224(2):526-33. PubMed ID: 6870278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization of TCDD differs between the liver, lungs, and kidneys after acute and subchronic exposure: species/dose comparisons and possible mechanism.
    Santostefano MJ; Johnson KL; Whisnant NA; Richardson VM; DeVito MJ; Diliberto JJ; Birnbaum LS
    Fundam Appl Toxicol; 1996 Dec; 34(2):265-75. PubMed ID: 8954756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearance of autolysosomes in rat liver after leupeptin treatment.
    Furuno K; Ishikawa T; Kato K
    J Biochem; 1982 May; 91(5):1485-94. PubMed ID: 6178729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of human interferon-beta in monkeys.
    Hilfenhaus J; Damm H; Hofstaetter T; Mauler R; Ronneberger H; Weinmann E
    J Interferon Res; 1981; 1(3):427-36. PubMed ID: 6180075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for human interferon alpha on bovine cells: specificity and tissue distribution.
    Chambers PJ; Saltis J; Alin P; Wright A; Linnane AW; Cheetham BF
    Immunopharmacol Immunotoxicol; 1990; 12(3):513-25. PubMed ID: 2148343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lysosomal proteinase inhibition on the development of the rat embryo in vitro.
    Daston GP; Baines D; Yonker JE; Lehman-McKeeman LD
    Teratology; 1991 Mar; 43(3):253-61. PubMed ID: 2014487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo.
    Bolli R; Cannon RO; Speir E; Goldstein RE; Epstein SE
    J Am Coll Cardiol; 1983 Oct; 2(4):671-80. PubMed ID: 6350399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-induced changes in pharmacokinetics and tumor uptake of 111In-labeled antimelanoma antibody 96.5 in melanoma patients.
    Rosenblum MG; Lamki LM; Murray JL; Carlo DJ; Gutterman JU
    J Natl Cancer Inst; 1988 Apr; 80(3):160-5. PubMed ID: 3346909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy.
    DeStefano E; Friedman RM; Friedman-Kien AE; Goedert JJ; Henriksen D; Preble OT; Sonnabend JA; Vilcek J
    J Infect Dis; 1982 Oct; 146(4):451-9. PubMed ID: 7119475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leupeptin as a tool for the detection of the sites of catabolism of rat high-density lipoprotein apolipoproteins A-I and E.
    van 't Hooft FM; Dallinga-Thie GM; van Tol A
    Biochim Biophys Acta; 1985 Mar; 834(1):75-84. PubMed ID: 2579677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of thiols, pH and cathepsin D in the lysosomal catabolism of serum albumin.
    Mego JL
    Biochem J; 1984 Mar; 218(3):775-83. PubMed ID: 6721834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective role of cathepsins B and D in the lysosomal degradation of endogenous and exogenous proteins.
    Kominami E; Ueno T; Muno D; Katunuma N
    FEBS Lett; 1991 Aug; 287(1-2):189-92. PubMed ID: 1715285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of leupeptin and pepstatin on protein turnover in adult rat hepatocytes in primary culture.
    Tanaka K; Ikegaki N; Ichihara A
    Arch Biochem Biophys; 1981 Apr; 208(1):296-304. PubMed ID: 7259184
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of rat liver fructose biphosphate aldolase by lysosomal proteinases.
    Katunuma N; Kominami E; Hashida S; Wakamatsu N
    Adv Enzyme Regul; 1982; 20():337-50. PubMed ID: 7051771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.